moxalactam has been researched along with Endocarditis, Bacterial in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
Bansal, MB; Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H | 1 |
Carbon, C; Contrepois, A; Garaud, JJ; Meulemans, A; Mohler, J; Pangon, B; Vallois, JM | 1 |
3 other study(ies) available for moxalactam and Endocarditis, Bacterial
Article | Year |
---|---|
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1984 |
Newer beta-lactam antibiotics in the treatment of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Rabbits; Staphylococcal Infections | 1984 |
Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
Topics: Animals; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Kinetics; Male; Microbial Sensitivity Tests; Moxalactam; Rabbits | 1986 |